|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.75 EUR | +0.25% |
|
+5.53% | +0.01% |
| May. 14 | FDA upheaval pushes some biotech firms to plan early trials out of US | RE |
| May. 12 | European shares close higher after Sino-US tariff deal relieves markets | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site
| Capitalization | 114B 130B 107B 96.34B 179B 11,084B 200B 1,238B 484B 5,026B 486B 476B 18,607B | P/E ratio 2025 * |
13.1x | P/E ratio 2026 * | 12.7x |
|---|---|---|---|---|---|
| Enterprise value | 120B 136B 112B 101B 188B 11,626B 210B 1,299B 508B 5,271B 509B 499B 19,516B | EV / Sales 2025 * |
2.65x | EV / Sales 2026 * | 2.41x |
| Free-Float |
87.31% | Yield 2025 * |
4.32% | Yield 2026 * | 4.57% |
More valuation ratios
* Estimated data
More news
Last Transcript: Sanofi
More press releases
More news
| 1 day | +0.25% | ||
| 1 week | +5.53% | ||
| Current month | -2.24% | ||
| 1 month | +3.35% | ||
| 3 months | -9.96% | ||
| 6 months | +3.17% | ||
| Current year | +0.01% |
| 1 week | 90.93 |  | 94.1 |
| 1 month | 87 | | 98.36 |
| Current year | 86.14 | | 110.88 |
| 1 year | 85.94 | | 110.88 |
| 3 years | 76.45 | | 110.88 |
| 5 years | 74.92 | | 110.88 |
| 10 years | 62.5 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 57 | 2019-08-31 |
| Director of Finance/CFO | 63 | 2024-03-31 | |
Madeleine Roach
COO | Chief Operating Officer | 41 | 2023-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 2013-05-02 | |
Patrick Kron
BRD | Director/Board Member | 71 | 2014-04-30 |
| Director/Board Member | 59 | 2019-04-29 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 3.66% | 139 M€ | +14.15% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.25% | +5.53% | +4.17% | -8.36% | 128B | ||
| -2.95% | +1.31% | -9.74% | +142.58% | 671B | ||
| -0.31% | +4.66% | +1.28% | -13.45% | 370B | ||
| -1.65% | +2.46% | +11.58% | +20.39% | 327B | ||
| +0.10% | +5.49% | -50.75% | +19.95% | 306B | ||
| -0.30% | +3.18% | +12.03% | -17.86% | 254B | ||
| +0.50% | +4.95% | -0.14% | +8.14% | 220B | ||
| +0.71% | +4.69% | -15.14% | -0.02% | 216B | ||
| -1.27% | +4.78% | -41.13% | -17.71% | 196B | ||
| -1.33% | +3.45% | -13.82% | +9.63% | 148B | ||
| Average | -0.43% | +3.31% | -10.17% | +14.33% | 283.43B | |
| Weighted average by Cap. | -0.86% | +2.97% | -9.74% | +34.41% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 45.22B 51.28B 42.32B 38.15B 70.91B 4,389B 79.33B 490B 192B 1,990B 192B 188B 7,368B | 48.27B 54.73B 45.17B 40.71B 75.68B 4,684B 84.67B 523B 205B 2,124B 205B 201B 7,863B |
| Net income | 8.83B 10.02B 8.27B 7.45B 13.85B 857B 15.49B 95.76B 37.45B 389B 37.57B 36.79B 1,439B | 9.15B 10.37B 8.56B 7.72B 14.35B 888B 16.05B 99.2B 38.8B 403B 38.91B 38.11B 1,491B |
| Net Debt | 5.58B 6.33B 5.22B 4.71B 8.75B 542B 9.79B 60.51B 23.66B 246B 23.73B 23.24B 909B | 2.06B 2.34B 1.93B 1.74B 3.23B 200B 3.62B 22.36B 8.75B 90.77B 8.77B 8.59B 336B |
More financial data
* Estimated data
Employees
82,878
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-05-21 | 93.75 € | +0.25% | 1,612,621 |
| 25-05-20 | 93.52 € | +1.37% | 1,893,715 |
| 25-05-19 | 92.26 € | +0.51% | 1,476,252 |
| 25-05-16 | 91.79 € | +2.14% | 2,310,105 |
| 25-05-15 | 89.87 € | +1.16% | 1,656,539 |
Real-time Euronext Paris, May 21, 2025 at 11:39 am EDT
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
93.75EUR
Average target price
117.70EUR
Spread / Average Target
+25.55%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
